Overview

Evaluation of Histamine, CGRP and VIP as Markers for Activation of Trigeminal and Parasympathetic Nerve Fibers

Status:
Completed
Trial end date:
2005-11-01
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to evaluate histamine, CGRP and VIP levels in saliva as biological markers for activation of trigeminal and parasympathetic nerve fibers in various clinical presentations of primary headaches compared to allergic rhinosinusitis and control populations.
Phase:
Phase 4
Details
Lead Sponsor:
Clinvest
Collaborator:
Ortho-McNeil Neurologics, Inc.
Treatments:
Almotriptan
Ephedrine
Histamine
Histamine phosphate
Pseudoephedrine